Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of PHMB Ophthalmic Solution in Healthy Subjects
NCT02506257Phase 1Completed
- Sponsor
- SIFI SpA
- Start
- Nov 2015
- Primary completion
- Apr 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of polihexanide in Acanthamoeba keratitis (AK) (4 arms), sponsored by SIFI SpA. Primary endpoint: Number of Subjects With Dose-limiting Adverse Events at 21 days. Started Nov 2015; status: completed.
02
Drugs
polihexanide
03
Conditions
Acanthamoeba keratitis (AK)
Beyond the preview
Go deeper on NCT02506257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506257.